Impact Biomedical Stock Performance
| IBO Stock | USD 0.47 0.02 4.08% |
The company retains a Market Volatility (i.e., Beta) of 0.75, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Impact BioMedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Impact BioMedical is expected to be smaller as well. At this point, Impact BioMedical has a negative expected return of -0.0413%. Please make sure to check out Impact BioMedical's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Impact BioMedical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Impact BioMedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Impact BioMedical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 1438.00 | |
| Total Cashflows From Investing Activities | 2876.00 |
Impact BioMedical Relative Risk vs. Return Landscape
If you would invest 56.00 in Impact BioMedical on November 8, 2025 and sell it today you would lose (9.00) from holding Impact BioMedical or give up 16.07% of portfolio value over 90 days. Impact BioMedical is generating negative expected returns assuming volatility of 7.6487% on return distribution over 90 days investment horizon. In other words, 68% of stocks are less volatile than Impact, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Impact BioMedical Target Price Odds to finish over Current Price
The tendency of Impact Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.47 | 90 days | 0.47 | about 69.06 |
Based on a normal probability distribution, the odds of Impact BioMedical to move above the current price in 90 days from now is about 69.06 (This Impact BioMedical probability density function shows the probability of Impact Stock to fall within a particular range of prices over 90 days) .
Impact BioMedical Price Density |
| Price |
Predictive Modules for Impact BioMedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Impact BioMedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Impact BioMedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Impact BioMedical is not an exception. The market had few large corrections towards the Impact BioMedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Impact BioMedical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Impact BioMedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.11 | |
β | Beta against Dow Jones | 0.75 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | -0.02 |
Impact BioMedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Impact BioMedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Impact BioMedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Impact BioMedical generated a negative expected return over the last 90 days | |
| Impact BioMedical has high historical volatility and very poor performance | |
| Impact BioMedical has some characteristics of a very speculative penny stock | |
| Impact BioMedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 2.33 M. Reported Net Loss for the year was (35.53 M) with profit before taxes, overhead, and interest of 23 K. | |
| Impact BioMedical has about 2 M in cash with (5.64 M) of positive cash flow from operations. | |
| Impact BioMedical has a very weak financial position based on the latest SEC disclosures | |
| Roughly 89.0% of the company shares are held by company insiders |
Impact BioMedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Impact Stock often depends not only on the future outlook of the current and potential Impact BioMedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Impact BioMedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.8 M | |
| Cash And Short Term Investments | 2 M |
Impact BioMedical Fundamentals Growth
Impact Stock prices reflect investors' perceptions of the future prospects and financial health of Impact BioMedical, and Impact BioMedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Impact Stock performance.
| Return On Equity | -3.47 | ||||
| Return On Asset | -0.0768 | ||||
| Operating Margin | (52.67) % | ||||
| Current Valuation | 74.19 M | ||||
| Shares Outstanding | 104.62 M | ||||
| Price To Book | 1.24 X | ||||
| Price To Sales | 2,035 X | ||||
| Revenue | 2.33 M | ||||
| EBITDA | (1.54 M) | ||||
| Cash And Equivalents | 2 M | ||||
| Total Debt | 8.88 M | ||||
| Book Value Per Share | (0.97) X | ||||
| Cash Flow From Operations | (5.64 M) | ||||
| Earnings Per Share | (3.91) X | ||||
| Total Asset | 20.29 M | ||||
| Retained Earnings | (37.67 M) | ||||
About Impact BioMedical Performance
By examining Impact BioMedical's fundamental ratios, stakeholders can obtain critical insights into Impact BioMedical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Impact BioMedical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Impact BioMedical performance evaluation
Checking the ongoing alerts about Impact BioMedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Impact BioMedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Impact BioMedical generated a negative expected return over the last 90 days | |
| Impact BioMedical has high historical volatility and very poor performance | |
| Impact BioMedical has some characteristics of a very speculative penny stock | |
| Impact BioMedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 2.33 M. Reported Net Loss for the year was (35.53 M) with profit before taxes, overhead, and interest of 23 K. | |
| Impact BioMedical has about 2 M in cash with (5.64 M) of positive cash flow from operations. | |
| Impact BioMedical has a very weak financial position based on the latest SEC disclosures | |
| Roughly 89.0% of the company shares are held by company insiders |
- Analyzing Impact BioMedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Impact BioMedical's stock is overvalued or undervalued compared to its peers.
- Examining Impact BioMedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Impact BioMedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Impact BioMedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Impact BioMedical's stock. These opinions can provide insight into Impact BioMedical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Biotechnology sector continue expanding? Could Impact diversify its offerings? Factors like these will boost the valuation of Impact BioMedical. Market participants price Impact higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Impact BioMedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Impact BioMedical's market price often diverges from its book value, the accounting figure shown on Impact's balance sheet. Smart investors calculate Impact BioMedical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Impact BioMedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.